Martín, Iván

Impact of clinical features, cytogenetics, genetic mutations, and methylation dynamics of CDKN2B and DLC-1 promoters on treatment response to azacitidine. [electronic resource] - Annals of hematology Mar 2020 - 527-537 p. digital

Publication Type: Clinical Trial; Journal Article

1432-0584

10.1007/s00277-020-03932-8 doi


Aged
Aged, 80 and over
Azacitidine--administration & dosage
Chromosome Deletion
Chromosomes, Human, Pair 7--genetics
Cyclin-Dependent Kinase Inhibitor p15--genetics
DNA Methylation--drug effects
DNA, Neoplasm--genetics
Disease-Free Survival
Female
GTPase-Activating Proteins--genetics
Humans
Leukemia, Myeloid, Acute--drug therapy
Male
Middle Aged
Myelodysplastic Syndromes--drug therapy
Nucleophosmin
Promoter Regions, Genetic
Survival Rate
Tumor Suppressor Proteins--genetics